Annual CFF
$132.53 M
+$65.35 M+97.26%
December 31, 2023
Summary
- As of February 7, 2025, WVE annual cash flow from financing activities is $132.53 million, with the most recent change of +$65.35 million (+97.26%) on December 31, 2023.
- During the last 3 years, WVE annual CFF has fallen by -$22.00 million (-14.24%).
- WVE annual CFF is now -24.52% below its all-time high of $175.59 million, reached on December 31, 2015.
Performance
WVE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$203.75 M
+$203.09 M+31101.53%
September 30, 2024
Summary
- As of February 7, 2025, WVE quarterly cash flow from financing activities is $203.75 million, with the most recent change of +$203.09 million (+31101.53%) on September 30, 2024.
- Over the past year, WVE quarterly CFF has increased by +$109.78 million (+116.84%).
- WVE quarterly CFF is now at all-time high.
Performance
WVE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$312.87 M
+$202.08 M+182.39%
September 30, 2024
Summary
- As of February 7, 2025, WVE TTM cash flow from financing activities is $312.87 million, with the most recent change of +$202.08 million (+182.39%) on September 30, 2024.
- Over the past year, WVE TTM CFF has increased by +$180.34 million (+136.07%).
- WVE TTM CFF is now at all-time high.
Performance
WVE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
WVE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.3% | +116.8% | +136.1% |
| 3 y3 years | -14.2% | +116.8% | +136.1% |
| 5 y5 years | +103.6% | +116.8% | +136.1% |
WVE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.4% | at high | >+9999.0% | at high | +746.2% |
| 5 y | 5-year | -19.4% | +137.4% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | -24.5% | +3509.3% | at high | >+9999.0% | at high | >+9999.0% |
Wave Life Sciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $203.75 M(>+9900.0%) | $312.87 M(+182.4%) |
| Jun 2024 | - | $653.00 K(-95.5%) | $110.80 M(-1.1%) |
| Mar 2024 | - | $14.51 M(-84.6%) | $111.99 M(-15.5%) |
| Dec 2023 | $132.53 M(+97.3%) | $93.96 M(+5526.5%) | $132.53 M(+243.1%) |
| Sep 2023 | - | $1.67 M(-9.7%) | $38.63 M(+4.5%) |
| Jun 2023 | - | $1.85 M(-94.7%) | $36.97 M(-63.4%) |
| Mar 2023 | - | $35.05 M(>+9900.0%) | $100.92 M(+50.2%) |
| Dec 2022 | $67.19 M(+20.3%) | $55.00 K(+223.5%) | $67.19 M(-33.4%) |
| Sep 2022 | - | $17.00 K(-100.0%) | $100.93 M(-7.6%) |
| Jun 2022 | - | $65.80 M(+4900.0%) | $109.26 M(+125.3%) |
| Mar 2022 | - | $1.32 M(-96.1%) | $48.50 M(-13.1%) |
| Dec 2021 | $55.83 M(-63.9%) | $33.79 M(+304.8%) | $55.83 M(+153.1%) |
| Sep 2021 | - | $8.35 M(+65.5%) | $22.05 M(-85.9%) |
| Jun 2021 | - | $5.04 M(-41.6%) | $156.23 M(-3.9%) |
| Mar 2021 | - | $8.64 M(>+9900.0%) | $162.56 M(+5.2%) |
| Dec 2020 | $154.54 M(-6.0%) | $19.00 K(-100.0%) | $154.54 M(-0.5%) |
| Sep 2020 | - | $142.52 M(+1152.2%) | $155.28 M(+1093.9%) |
| Jun 2020 | - | $11.38 M(+1753.7%) | $13.01 M(+786.6%) |
| Mar 2020 | - | $614.00 K(-18.9%) | $1.47 M(-99.1%) |
| Dec 2019 | $164.40 M | $757.00 K(+199.2%) | $164.40 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $253.00 K(-261.1%) | $164.29 M(-0.7%) |
| Jun 2019 | - | -$157.00 K(-100.1%) | $165.39 M(-27.2%) |
| Mar 2019 | - | $163.55 M(>+9900.0%) | $227.10 M(+248.9%) |
| Dec 2018 | $65.09 M(-31.0%) | $646.00 K(-52.2%) | $65.09 M(+0.1%) |
| Sep 2018 | - | $1.35 M(-97.8%) | $65.04 M(+2.0%) |
| Jun 2018 | - | $61.56 M(+3905.2%) | $63.74 M(-33.4%) |
| Mar 2018 | - | $1.54 M(+161.0%) | $95.72 M(+1.4%) |
| Dec 2017 | $94.37 M(+224.1%) | $589.00 K(+898.3%) | $94.37 M(+0.6%) |
| Sep 2017 | - | $59.00 K(-99.9%) | $93.80 M(-0.1%) |
| Jun 2017 | - | $93.54 M(>+9900.0%) | $93.92 M(+220.3%) |
| Mar 2017 | - | $190.00 K(+1166.7%) | $29.33 M(+0.7%) |
| Dec 2016 | $29.12 M(-83.4%) | $15.00 K(-91.8%) | $29.12 M(-77.9%) |
| Sep 2016 | - | $184.00 K(-99.4%) | $131.84 M(-31.6%) |
| Jun 2016 | - | $28.94 M(<-9900.0%) | $192.87 M(+17.6%) |
| Mar 2016 | - | -$16.00 K(-100.0%) | $163.95 M(-6.6%) |
| Dec 2015 | $175.59 M(+3025.0%) | $102.74 M(+67.8%) | $175.59 M(+141.0%) |
| Sep 2015 | - | $61.21 M(>+9900.0%) | $72.86 M(+525.6%) |
| Jun 2015 | - | $15.00 K(-99.9%) | $11.65 M(+0.1%) |
| Mar 2015 | - | $11.63 M | $11.63 M |
| Dec 2014 | $5.62 M(+53.0%) | - | - |
| Dec 2013 | $3.67 M | - | - |
FAQ
- What is Wave Life Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for Wave Life Sciences?
- What is Wave Life Sciences annual CFF year-on-year change?
- What is Wave Life Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Wave Life Sciences?
- What is Wave Life Sciences quarterly CFF year-on-year change?
- What is Wave Life Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Wave Life Sciences?
- What is Wave Life Sciences TTM CFF year-on-year change?
What is Wave Life Sciences annual cash flow from financing activities?
The current annual CFF of WVE is $132.53 M
What is the all time high annual CFF for Wave Life Sciences?
Wave Life Sciences all-time high annual cash flow from financing activities is $175.59 M
What is Wave Life Sciences annual CFF year-on-year change?
Over the past year, WVE annual cash flow from financing activities has changed by +$65.35 M (+97.26%)
What is Wave Life Sciences quarterly cash flow from financing activities?
The current quarterly CFF of WVE is $203.75 M
What is the all time high quarterly CFF for Wave Life Sciences?
Wave Life Sciences all-time high quarterly cash flow from financing activities is $203.75 M
What is Wave Life Sciences quarterly CFF year-on-year change?
Over the past year, WVE quarterly cash flow from financing activities has changed by +$109.78 M (+116.84%)
What is Wave Life Sciences TTM cash flow from financing activities?
The current TTM CFF of WVE is $312.87 M
What is the all time high TTM CFF for Wave Life Sciences?
Wave Life Sciences all-time high TTM cash flow from financing activities is $312.87 M
What is Wave Life Sciences TTM CFF year-on-year change?
Over the past year, WVE TTM cash flow from financing activities has changed by +$180.34 M (+136.07%)